The five-year survival rate of patients with stage III cervical cancer, after treatment with radiotherapy and chemotherapy, is about 20% to 30%. Cervical cancer is a common malignant tumor of the reproductive system in women, and the occurrence of the disease is related to many factors, such as human papillomavirus infection and heredity. Stage III cervical cancer is in the middle to late stage, which means the tumor has extended to the lower third of the vagina and/or invaded the pelvic wall. During this period, patients can obtain a five-year survival rate of about 20% to 30% after radiotherapy and chemotherapy. Commonly used radiotherapy methods include three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, etc. Commonly used chemotherapeutic drugs include cisplatin, paclitaxel, etc., which need to be applied under the guidance of doctors. It is recommended that patients maintain a good attitude and actively treat the disease to avoid delays.